Moderna (MRNA) announced that the Medicines and Healthcare products Regulatory Agency in the UK has granted marketing authorization for mRESVIA, indicated for active immunization for the prevention of ...

Health updates cover U.S. involvement in WHO meetings, UK approval of Moderna's RSV vaccine, a Texas measles outbreak, FDA ...

The shot, also known as the mRESVIA is used for preventing the lower respiratory tract disease in older adults. As per the ...

Here are four respiratory illness updates: On a national level, influenza test positivity decreased to 24.5%, while COVID-19 and RSV positivity rates remained steady at 4.3% and 7.1%. Wastewater ...

The overall number of respiratory virus cases in hospital emergency departments dropped for the second consecutive week — a potential sign the flu season has peaked.

While there are usually cases and even minor outbreaks reported yearly, the 2025 outbreak is on track to be the largest in ...

RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regu ...

Robust immune responses were observed among healthy and high-risk younger adults who received the Ad26/protein RSV preF vaccine.

Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...

Health officials say a child who had not been vaccinated died of measles in West Texas — the first death in an outbreak that has now infected more than 140 people​.

The vaccine, manufactured by US pharmaceutical giant Moderna, was found to slash the risk of severe illness from respiratory ...